Biological Role of Anions (Sulfate, Nitrate , Oxalate and Acetate)
on the Antibacterial Properties of Cobalt (II) and Nickel(II)
Complexes With Pyrazinedicarboxaimide Derived, Furanyl and Thienyl
Compounds by Chohan, Zahid H. & Praveen, M.
BIOLOGICAL ROLE OF ANIONS (SULFATE, NITRATE,
OXALATE AND ACETATE) ON THE ANTIBACTERIAL PROPERTIES
OF COBALT(II) AND NICKEL(II) COMPLEXES
WITH PYRAZlNEDICARBOXAIMIDE DERIVED, FURANYL AND
THIENYL COMPOUNDS
Zahid H. Chohan* and M. Praveen2
Department of Chemistry, Islamia University, Bahawalpur, Pakistan
Department of Chemistry, Washington University, St. Louis 63130, USA
ABSTRACT:
A number of biologically active complexes of cobalt(II) and nickel(II) with pyrazinedicarboxaimido derived
thienyl and furanyl compounds having the same metal ion but different anions such as sulphate, nitrate,
oxalate and acetate have been synthesized and characterized on the basis of their physical, spectral and
analytical data. In order to evaluate the role of anions on their antibacterial properties, these ligands and
their synthesized metal complexes with various anions have been screened against bacterial species
Escherichia coil Pseztdomonas aeruginosa and Staphylococcus aurezs. The title studies have proved a
definitive role of anions in increasing the antibacterial properties.
INTRODUCTION
Several reviews and studies in the literature-
have discussed the role of metal ions in biological systems.
There is no longer any controversy in researches
6-9 that certain types of cancers are viruses associated. The
potentiality and affectivity of anticancer drugs have strongly shown their direct relationship
1-13 with the
metal ions. Such a biological role of metal ions is, also, obvious and well known
14"16 in many antibacterial
drugs. Our previous studies
172 have systematically elaborated this relationship of metal ions in
subsequently increasing the activity of bactericidal compounds. This relationship of metal ions and the
biochemical processes ought to gain awareness of those factors, which are responsible in enhancing the
biological activity. In exploration of these factors, we, wish to report in the preceding paper the possible
role of anions (sulfate, nitrate, oxalate and acetate) which stay as a counter part of the metal ion (cation) in
the complex.
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Fig. 1: Structure of the Ligand
Experimental
Materials and Methods
All chemicals and solvents used were of Analar grade. All the metals were used as their metal(II) chlorides.
IR, H NMR and 3C NMR spectra were recorded on Philips Analytical PU 9800 FTIR and Brucker 250
MHz instruments. UV- Visible spectra were obtained on a Hitachi U-2000 double-beam spectrophotometer.
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Conductance of the metal complexes was determined in DMF on a YSI-32 model conductometer. Magnetic
measurements were done on solid complexes using the Gouy method. Melting points were recorded on a
Gallenkamp apparatus and are uncorrected. The antibacterial studies were carried out with the help of the
Department of Pathology, Quaid-e-Azam Medical College, Bahawalpur, Pakistan.
Preparation of Ligands
The ligands were prepared by adopting the same procedure as reported earlier
3 by us. The structural
determination of these ligands was done with the help of their IR, H-NMR, 3C-NMR and microanalytical
data.
Preparation of Metal Complexes
To a hot n_-butanol solution (30 mL) of the ligand (0.02 mol) was added an ethanolic solution (25 mL) of
the respective metal(II) salt (0.01 mol). The mixture was refluxed for 2 h. The resulting mixture was
cooled, filtered and reduced to half of its volume (20 mL). The concentrated solution so obtained was left
overnight at room temperature which resulted in the formation of a solid product. The product thus formed
was filtered, washed with n-butanol (2x10 mL), then with ethanol (2xl 0 mL) followed by ether (2x20 mL)
and dried. Crystallization in hot aqueous n-butanol (50 %) gave 1 (68 %), 2 (65 %), 3 (65 %), 4 (67 %), 5
(65 %), 6 (69 %), 7 (65 %), 8 (60), 9 (58 %), 10 (63 %), 11 (65 %), 12 (65 %), 13 (67 %), 14 (68 %), 15
(65 %) and 16 (66 %).
Antibacterial Studies
Preparation of Discs.
The ligand/complex (30 lag) in DMF (0.01mL) was applied on a paper disc, [prepared from blotting paper
(3 mm diameter)] with the help of a micropipette. The discs were left in an incubator for 48 h at 37C and
then applied on the bacteria grown agar plates.
Preparation of Agar Plates.
Minimal agar was used for the growth of specific bacterial species. For the preparation of agar plates for
Escherichia coli, MacConkey agar (50 g), obtained from Merck Chemical Company, was suspended in
freshly distilled water (1 L). It was allowed to soak for 15 minutes and then boiled on a water bath until the
agar was completely dissolved. The mixture was autoclaved for 15 minutes at 120C and then poured into
previously washed and sterilized Petri dishes and stored at 40C for inoculation.
Procedure of Inoculation.
Inoculation was done with the help of a platinum wire loop which was made red hot in a flame, cooled and
then use for the application of bacterial strains.
Application of Discs.
A sterilized forceps was used for the application of paper disc on the already inoculated agar plates. When
the discs were applied, they were incubated at 37C for 24 h. The zone of inhibition was then measured (in
diameter) around the disc.
RESULTS AND DISCUSSION
All the metal complexes were synthesized by a stoichiometric reaction of metal(II) salt having different
anions and the respective ligands in a molar ratio 2 M L (metal ligand). All complexes are air and
moisture stable solids, soluble in DMF, DMSO and water and partially soluble in ethanol, acetone and
benzene. The conductivity measurements (20-28 ohm-
cm mol-) of these complexes in DMF
"1 ndlcated them to be non-electrolytes.
Infrared Spectra
The bonding of the ligand to the metal ion was investigated by mainly comparing the infrared spectra of
the free iigands with the spectra of their metal complexes. The infrared spectra show a positive shift of
bands at 1510 cm due to skeletal modes of the pyrazine ring, indicating
23 co-ordination through pyrazine
ring nitrogen. Also, an insignificant shift of v(C=O) at 1670 cm indicated that it is not co-ordinated to
the metal atom. The spectra of all complexes (Table 2) also indicated that a band at 1640 cm due to
azomethine v(C=N) linkage was shifted towards lower frequency by 5-10 cm-, respectively, suggesting
that the ligands are involved in co-ordination to the metal atom via the azomethine nitrogen. The new
bands appearing in the spectra of metal complexes and not observed in the spectra of the ligands within
442-455 cm and 375-386 cm assigned to M-O and M-S modes, respectively, gave a definitive clue
24 that
the heteroatoms X (Fig 1) are also involved in the co-ordination.
Magnetic Moment
The room temperature magnetic susceptibility measurements (Table 1) for the solid complexes lie within
the range expected for their octahedral geometry. Three unpaired electrons per Co(II) ion (bterf=4.35-4.87
su=ested octahedral geometry for B.M) and two unpaired electrons per Ni(lI) ion (geff--2.85-3.24 B.M)
s 6
Co(lI) and Ni(ll) complexes.
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Table
No
Physical And Analytical Data of Metal Chelates
Metal chelate/ M.P(C)
Mol. Formula (decom)
[Co(L l):,(SOa)2]
C32H2oCoN4O12S2
[895.37]
2 [Co(L’)2(NO3)]
C32HzoCoNsO7
[765.25]
3 [Co(L)2(C204)2]
C36H2oCoN4OI2
[879.25]
4 [Co(L)z(CH3CO2)]
C34Hz3N406
[762.25]
5 [Co(L2)2(SO4)2]
C32H2oCoN40oS2
[959.611
6 [Co(LZ)z(NO3)]
C32HzoCoNsOsS
[825.49]
7 [Co(L2)2(C204)2]
C36H2oCoN4OioS
[943.49]
8 [Co(L2)2(CHsCO2)]
C34H23CoN404S
[826.49]
9 [Ni(L’)2(SO4)2]
C32H2oNiN402S2
[895.13]
10 [Ni(L’)2(NO3)
C32H2oNiNsO7
[76.0]
11 [Ni(L’)2(C20.)2]
C36H2oNiN402
[879.01]
12 [Ni(L)z(CH3CO2)]
C34Hz3NiN406
[762.01]
13 [Ni(LZ)z(SOa)2]
C32H2oNiN4OloS2
[959.37]
14 [Ni(L2)z(NO3)]
C32HzoNiNsOsS
[829.25]
15 [Ni(L2)2(C204)2]
C36H2oNiN40oS
[943.25]
16 [Ni(L)2(CH3CO2)]
C32H2oNiN4OlzS2
[826.25]
B.M Calc (Found)%
(l.tef0 C H N
209-211 4.68 42.9 2.2 6.2
(43.3) (2.5) (6.6)
217-219 4.45 50.2 2.6 9.1
(49.9) (2.6) (9.4)
201-203 4.35 49.2 2.3 6.4
(50.1) (2.9) (6.8)
228-230 4.87 53.6 3.0 7.3
(53.2) (2.8) (7.6)
233-235 4.64 40.’0 2.1 5.8
(39.7) (2.2) (5.5)
210-212 4.82 46.3 2.4 8.4
(46.2) (2.3) (8.9)
225-227 4.55 45.8 2.1 5.9
(46.1) (2.4) (6.0)
222-224 4.85 4914 2.8 6.8
228-230 2.85
(49.2) (2.5) (6.7)
42.9 2.2 6.3
(42.7) (2.2) (6.7)
218-220 2.91 50.2 2.6 9.2
(50.5) (2.8) (9.4)
202-204 3.24 49.2 2.3 6.4
(49.4) (2.5) (6.1)
210-212 3.22 53.6 3.0 7.3
(53.4) (3.1) (7.6)
225-227 2.95 40.1 2.1 5.8
(39.8)(2.3)(5.5)
213-215 3.12 46.3 2.4 8.4
(46.8) (2.5) (8.2)
206-208 2.88 45.8 2.1 5.9
(45.6) (2.0) (6.2)
211-213 2.97 46.5 2.4 6.7
(46.2) (2.3) (6.7)
Electronic Spectra
Electronic spectra of the metal complexes are recorded in Table 2. The spectra of the cobalt chelates show
three bands observed at 8725-9555 cm, 17365-18285 cm and 29515-31255 cm which may be
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assigned
27 to 4Tlg 4T2g (F), 4Tlg ---) 4A2g (F) and 4Tlg ---) 4T
28 lg (P) transitions, respectively, and are
suggestive of octahedral geometry around the cobalt ion. Three bands observed at 9315-10312 cm,
15870-17125 cm-
and 26355-27550 cm
l in the spectra of the nickel(II) chelates are due to spin-allowed
transitions from 3Azg 3Tzg (F), 3A2g --+ 3Ag (F) and 3Azg --+ 3yg (P), transitions, respectively, in an
octahedral environment
Based on the above evidences, it is proposed that cobalt(II) and nickel(II) complexes have octahedral
geometry in which the ligands behave as tridentate and accommodate themselves in such a way that a
stable chelate ring is formed around the metal atom thus attaining a stable configuration.
Table 2 Spectral Data of Metal Chelates
No
2
3
4
5
6
7
8
9
10
ll
12
13
14
15
16
IR (cm-1)
1670 (C=O), 1630 (C=N), 1515 (pyrazine),445 (M-O)
1670 (C=O), 1635 (C=N), 1530 (pyrazine), 442 (M-O)
1670 (C=O), 1635 (C=N), 1533 (pyrazine) 442 (M-O)
1670 (C=O), 1632 (C=N), 1525 (pyrazine), 445 (M-O)
1670 (C=O), 1635 (C=N), 1530 (pyrazine), 375 (M-S)
1670 (C=O), 1635 (C=N), 1532 (pyrazine), 380 (M-S)
1670 (C=O), 1630 (C=N), 1535 (pyrazine) 385 (M-S)
1670 (C=O), 1635 (C=N), 1535 (pyrazine), 382 (M-S)
1670 (C=O), 1635 (C=N), 1537 (pyrazine), 445 (M-O)
1670 (C=O), 1635 (C=N), 1535 (pyrazine), 445 (M-O)
1670 (C=O), 1630 (C=N), 1535 (pyrazine), 445 (M-O)
1670 (C=O), 1635 (C=N), 1535 (pyrazine), 445 (M-O)
1670 (C=O), 1635 (C=N), 1535 (pyrazine), 375 (M-S)
1670 (C=O), 1630 (C=N), 1535 (pyrazine), 380 (M-O)
1670 (C=O), 1635 (C=N), 1535 (pyrazine), 385 (M-O)
1670 (C=O), 1630 (C=N), 1535 (pyrazine), 385 (M-O)
(cm -1)
29535, 18285, 8765
30865, 17365, 9555
30260, 18150, 8795
31255, 18185, 9390
29715, 17422, 9550
30525, 18257, 9255
30115, 17720, 9315
29575, 17522, 8905
26355, 15870, 9315
27550, 17125, 10312
26565, 16288, 9870
27235, 16542, 9755
26910, 16111,9785
27222, 17085, 9412
26721, 16295, 10188
27445, 15770, 9437
Table 3 Antibacterial Activity Data
Ligand/Chelate
E
Micro b a S
b
pec ie s
c
++
++ + +
+
++++ ++ +++
2 +++ +++ ++
3 +++ +++ +++
4 ++ ++++ +++
5 +++ ++++ +++
6 +++ +++ ++
7 +++ +++ +++
8 +++ +++ +++
9 ++++ ++++ +++
10 ++ ++ +
11 +++ +++ ++
12 +++ ++ +++
13 +++ ++ +++
14
15
16
+++ +++ +++
++ ++ ++++
+++ +++ ++
a=Escherichia coli, b=Pseudomonas aeruginosa, c=Staphylococcus aureus
Inhibition zone diameter mm (% inhibition): +, 6-10 (27-45 %); ++, 10-14 (45-64 %);
+++, 14-18 (64-82 %); ++++, 18-22 (82-100 %). Percent inhibition values are relative to inhibition zone
(22 ram) of the most active compound with 100 % inhibition.
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Antibacterial Studies
The title ligands in comparison to their metal complexes were screened against bacterial species
Escherichia coil, Pseudomonas aeruginosa and Staphylococcus aureus in order to determine their
antibacterial properties. The antibacterial activity was tested at a concentration 30tg/0/01 mL in DMF
using paper disc diffusion method. The results of these studies reproduced in Table 3 showed that ligands
and all their metal complexes are biologically active against one or more bacterial species and the metal
complexes having different anions have been shown to be more antibacterial than the simple uncomplexed
parent ligands.
These results clearly indicated that when the same metal chelate having different anions was individually
screened, the degree of bactericidal activity varied. For example, the Co(II) complex having nitrate as anion
was more bactericidal than the Co(II) complex with sulphate, oxalate or acetate anions. Similarly, the
Co(II) complex of oxalate anion was more antibacterial active than the complex with acetate, chloride or
sulphate anions. The same results were found for Ni(II) complexes. From the obtained data, it was
generally observed that the order of potency in comparison to the metal complexes having chloride anions
evaluated and reported earlier
3 and to the results of the present studies for the anions sulphate, nitrate,
oxalate and acetate against the tested bacterial species was found to follow the order as:
NO > C204 > CH3CO > CI > SO4.
On the basis of these results, we strongly claim that different anions do effect the biological behavior of the
metal chelates. However, at this stage, we are not aware of the actual mechanism. It is however, suspected
that factors such as solubility, conductivity, dipole moment and cell permeability mechanism (influenced
by the presence of anions) may be the possible reasons for effecting the activity.
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